Hasegawa et al. previously reported that serum levels of interleukin (IL)-4, IL-10, and IL-13 were elevated in patients with SSc (Hasegawa et al. 1997; Hasegawa 1998). The gene discussed is IL10; the disease is systemic sclerosis.